251 related articles for article (PubMed ID: 24007149)
1. In vivo dosimetry with optically stimulated dosimeters and RTQA2 radiochromic film for intraoperative radiotherapy of the breast.
Price C; Pederson A; Frazier C; Duttenhaver J
Med Phys; 2013 Sep; 40(9):091716. PubMed ID: 24007149
[TBL] [Abstract][Full Text] [Related]
2. In vivo dosimetry with radiochromic films in low-voltage intraoperative radiotherapy of the breast.
Avanzo M; Rink A; Dassie A; Massarut S; Roncadin M; Borsatti E; Capra E
Med Phys; 2012 May; 39(5):2359-68. PubMed ID: 22559606
[TBL] [Abstract][Full Text] [Related]
3. A skin dose prediction model based on in vivo dosimetry and ultrasound skin bridge measurements during intraoperative breast radiation therapy.
Brodin NP; Mehta KJ; Basavatia A; Goddard LC; Fox JL; Feldman SM; McEvoy MP; Tomé WA
Brachytherapy; 2019; 18(5):720-726. PubMed ID: 31229364
[TBL] [Abstract][Full Text] [Related]
4. In vivo dosimetry with optically stimulated luminescent dosimeters, OSLDs, compared to diodes; the effects of buildup cap thickness and fabrication material.
Jursinic PA; Yahnke CJ
Med Phys; 2011 Oct; 38(10):5432-40. PubMed ID: 21992362
[TBL] [Abstract][Full Text] [Related]
5. Development and characterization of a three-dimensional radiochromic film stack dosimeter for megavoltage photon beam dosimetry.
McCaw TJ; Micka JA; DeWerd LA
Med Phys; 2014 May; 41(5):052104. PubMed ID: 24784393
[TBL] [Abstract][Full Text] [Related]
6. Radiochromic film calibration for low-energy seed brachytherapy dose measurement.
Morrison H; Menon G; Sloboda RS
Med Phys; 2014 Jul; 41(7):072101. PubMed ID: 24989396
[TBL] [Abstract][Full Text] [Related]
7. Measurement of surface dose in an MR-Linac with optically stimulated luminescence dosimeters for IMRT beam geometries.
Lim-Reinders S; Keller BM; Sahgal A; Chugh B; Kim A
Med Phys; 2020 Jul; 47(7):3133-3142. PubMed ID: 32302010
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of an OSLD in the diagnostic energy range.
Al-Senan RM; Hatab MR
Med Phys; 2011 Jul; 38(7):4396-405. PubMed ID: 21859040
[TBL] [Abstract][Full Text] [Related]
9. In vivo measurements for high dose rate brachytherapy with optically stimulated luminescent dosimeters.
Sharma R; Jursinic PA
Med Phys; 2013 Jul; 40(7):071730. PubMed ID: 23822434
[TBL] [Abstract][Full Text] [Related]
10. Application of the optically stimulated luminescence (OSL) technique for mouse dosimetry in micro-CT imaging.
Vrigneaud JM; Courteau A; Ranouil J; Morgand L; Raguin O; Walker P; Oudot A; Collin B; Brunotte F
Med Phys; 2013 Dec; 40(12):122102. PubMed ID: 24320529
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric impact of the AeroForm tissue expander in postmastectomy radiation therapy: an ex vivo analysis.
Moni J; Saleeby J; Bannon E; Lo YC; Fitzgerald TJ
Pract Radiat Oncol; 2015; 5(1):e1-8. PubMed ID: 25413421
[TBL] [Abstract][Full Text] [Related]
12. Comparative dose evaluations between XVI and OBI cone beam CT systems using Gafchromic XRQA2 film and nanoDot optical stimulated luminescence dosimeters.
Giaddui T; Cui Y; Galvin J; Yu Y; Xiao Y
Med Phys; 2013 Jun; 40(6):062102. PubMed ID: 23718600
[TBL] [Abstract][Full Text] [Related]
13. Radiochromic film dosimetry of HDR (192)Ir source radiation fields.
Aldelaijan S; Mohammed H; Tomic N; Liang LH; Deblois F; Sarfehnia A; Abdel-Rahman W; Seuntjens J; Devic S
Med Phys; 2011 Nov; 38(11):6074-83. PubMed ID: 22047372
[TBL] [Abstract][Full Text] [Related]
14. In vivo dosimetry in low-voltage IORT breast treatments with XR-RV3 radiochromic film.
Lozares S; Font JA; Gandía A; Campos A; Flamarique S; Ibáñez R; Villa D; Alba V; Jiménez S; Hernández M; Casamayor C; Vicente I; Hernando E; Rubio P
Phys Med; 2021 Jan; 81():173-181. PubMed ID: 33465753
[TBL] [Abstract][Full Text] [Related]
15. Validation of OSLD and a treatment planning system for surface dose determination in IMRT treatments.
Zhuang AH; Olch AJ
Med Phys; 2014 Aug; 41(8):081720. PubMed ID: 25086530
[TBL] [Abstract][Full Text] [Related]
16. Monte Carlo skin dose simulation in intraoperative radiotherapy of breast cancer using spherical applicators.
Moradi F; Ung NM; Khandaker MU; Mahdiraji GA; Saad M; Abdul Malik R; Bustam AZ; Zaili Z; Bradley DA
Phys Med Biol; 2017 Jul; 62(16):6550-6566. PubMed ID: 28708603
[TBL] [Abstract][Full Text] [Related]
17. SU-E-T-169: Initial Investigation into the Use of Optically Stimulated Luminescent Dosimeters (OSLDs) for In-Vivo Dosimetry of TBI Patients.
Paloor S; Aland T; Mathew J; Al-Hammadi N; Hammoud R
Med Phys; 2012 Jun; 39(6Part12):3742. PubMed ID: 28517806
[TBL] [Abstract][Full Text] [Related]
18. Electron radiotherapy (IOERT) for applications outside of the breast: Dosimetry and influence of tissue inhomogeneities.
Avanzo M; Dassie A; Chandra Acharya P; Chiovati P; Pirrone G; Avigo C; Barresi L; Dang Quoc S; Fiagbedzi E; Navarria F; Palazzari E; Bertola G; De Paoli A; Stancanello J; Sartor G
Phys Med; 2020 Jan; 69():82-89. PubMed ID: 31841774
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo study of the relationship between skin dose and optically stimulated luminescence dosimeter dose in Pd-103 permanent breast seed implant brachytherapy.
Nich S; Kirkby C; Villarreal-Barajas JE
Brachytherapy; 2019; 18(3):387-395. PubMed ID: 30792005
[TBL] [Abstract][Full Text] [Related]
20. Optically stimulated luminescence (OSL) of carbon-doped aluminum oxide (Al2O3:C) for film dosimetry in radiotherapy.
Schembri V; Heijmen BJ
Med Phys; 2007 Jun; 34(6):2113-8. PubMed ID: 17654914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
